Overcoming acquired resistance of EGFR‐mutant NSCLC cells to the third generation EGFR inhibitor, osimertinib, with the natural product honokiolHongjing Zang, Shi‐Yong Sun|Molecular Oncology|2020Cited by 38
MicroRNA-150-3p enhances the antitumour effects of CGP57380 and is associated with a favourable prognosis in non-small cell lung cancerHongmei Zheng, Hongjing Zang|Scientific Reports|2025Cited by 0